Old Web
English
Sign In
Acemap
>
authorDetail
>
Wangang Xie
Wangang Xie
AbbVie
Internal medicine
Medicine
Gastroenterology
Ulcerative colitis
Adverse effect
7
Papers
106
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OP24 Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
2021
Journal of Crohn's and Colitis
Silvio Danese
Severine Vermeire
Wen Zhou
Aileen L. Pangan
Jesse S. Siffledeen
Xavier Hébuterne
Hiroshi Nakase
Peter D.R. Higgins
M H Chen
Y. Sanchez Gonzalez
Bidan Huang
Wangang Xie
J. Liu
M A Weinreich
R Pannaccione
Show All
Source
Cite
Save
Citations (1)
OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
2021
Journal of Crohns & Colitis
Severine Vermeire
S. Danese
Wen Zhou
Aileen L. Pangan
S. Greenbloom
G. DHaens
Julià Panés
Pascal Juillerat
James O. Lindsay
Edward V. Loftus
W. J. Sandborn
Walter Reinisch
Y. Sanchez Gonzalez
Bidan Huang
Wangang Xie
J. Liu
M A Weinreich
Remo Panaccione
Show All
Source
Cite
Save
Citations (1)
OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study
2020
Journal of Crohns & Colitis
J.-F. Colombel
Julià Panés
G D’Haens
Stefan Schreiber
Remo Panaccione
L. Peyrin-Biroulet
Edward V. Loftus
Silvio Danese
Edward E. Louis
Alessandro Armuzzi
Marc Ferrante
Harald Vogelsang
J Lefebvre
T Doan
Wangang Xie
Bidan Huang
J Petersson
Jasmina Kalabic
Anne M. Robinson
William J. Sandborn
Show All
Source
Cite
Save
Citations (10)
P722 Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE study
2020
Journal of Crohns & Colitis
G D’Haens
Xavier Hébuterne
Peter D.R. Higgins
Edward V. Loftus
Wen Zhou
Ana P. Lacerda
Wangang Xie
Jianzhong Liu
Silvio Danese
Show All
Source
Cite
Save
Citations (0)
In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of HCV NS5A
2014
Antimicrobial Agents and Chemotherapy
Preethi Krishnan
Jill Beyer
Neeta Mistry
Gennadiy Koev
Thomas Reisch
David A. Degoey
Warren M. Kati
Andrew Campbell
Laura A. Williams
Wangang Xie
Carolyn Setze
Akhteruzzaman Molla
Christine A. Collins
Tami Pilot-Matias
Show All
Source
Cite
Save
Citations (92)
1